Obesity Clinical Trials in Houston

Showing 201-212 of 212 trials

Effectiveness of Brief Counseling for Weight Management

NCT00212199

The purpose of this study is to test the effectiveness of three different methods for delivering weight management information. Two methods utilize an obesity drug and the third method utilizes brief behavioral counseling sessions only.

1. Obesity

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)246 participantsStarted Jan 2002

Houston, Texas, United States

UNKNOWNPhase 3< 1 mile

Transoral Gastroplasty for the Treatment of Morbid Obesity

NCT00661245

The TOGA® trial is a prospective, multi-center, randomized sham-controlled trial designed to determine the safety and effectiveness of the TOGA System for the treatment of morbid obesity. The study will also determine the effect of the treatment on co-morbidities and quality of life. Subjects will be blinded to treatment or sham. Sham arm may crossover to TOGA treatment at 12 months.

Obesity

Satiety, Inc.275 participantsStarted Jul 2008

Los Angeles, California, United States • San Francisco, California, United States • Worcester, Massachusetts, United States +8 more locations

UNKNOWNPhase 2/3< 1 mile

Glaser Obesity Study

NCT00209482

This study will determine if the drug metformin, coupled with diet and exercise counseling, will help obese adolescents lose weight.

Obesity

Glaser Pediatric Research Network76 participantsStarted Oct 2003

Los Angeles, California, United States • San Francisco, California, United States • Stanford, California, United States +2 more locations

Effectiveness of Brief Counseling for Weight Management

Transoral Gastroplasty for the Treatment of Morbid Obesity

Glaser Obesity Study

Obesity Trials in Other Cities

Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

Obese Patients With Type 2 Diabetes

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss

An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients

Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to a Calorie-Restricted Diet in Women

Testing the Developmental Origins Hypothesis

Other Conditions in Houston